Kardigantm, a heart health company modernizing cardiovascular (CV) drug development, today announced its upcoming corporate presentation at the 2026 J.P. Morgan Healthcare Conference ("JPM 2026") on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback